KALV Historical PE Ratio image   This KALV PE ratio history page last updated 9/12/2022
KALV Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q1 2023
9/8/2022
15.84-0.94-3.76NA
Q4 2022
7/7/2022
10.98-0.98-3.92NA
Q3 2022
3/10/2022
16.38-0.92-3.68NA
Q2 2022
12/9/2021
13.73-0.80-3.20NA
Q1 2022
9/9/2021
21.11-0.66-2.64NA
Q4 2021
7/13/2021
21.81-0.65-2.60NA
Q3 2021
3/11/2021
30.99-0.56-2.24NA
Q2 2021
12/10/2020
17.53-0.58-2.32NA
Q1 2021
9/14/2020
13.99-0.61-2.44NA
Q4 2020
7/1/2020
12.12-0.37-1.48NA
Q3 2020
3/10/2020
10.40-0.52-2.08NA
Q2 2020
12/3/2019
15.34-0.33-1.32NA
Q1 2020
9/9/2019
16.60-0.42-1.68NA
Q4 2019
7/15/2019
17.00-0.49-1.96NA
Q3 2019
3/14/2019
31.10-0.23-0.92NA
Q2 2019
12/14/2018
22.68-0.22-0.88NA
Q1 2019
9/14/2018
17.17-0.47-1.88NA
Q4 2018
7/31/2018
9.37-0.06-0.24NA
Q3 2018
3/16/2018
10.07-0.49-1.96NA
Q2 2018
12/14/2017
9.21-0.50-2.00NA
KALV PE History Chart
PeriodPriceGAAPTTMPE
Q1 2023
9/8/2022
15.84-0.94-3.64NA
Q4 2022
7/7/2022
10.98-0.98-3.36NA
Q3 2022
3/10/2022
16.38-0.92-3.03NA
Q2 2022
12/9/2021
13.73-0.80-2.67NA
Q1 2022
9/9/2021
21.11-0.66-2.45NA
Q4 2021
7/13/2021
21.81-0.65-2.40NA
Q3 2021
3/11/2021
30.99-0.56-2.12NA
Q2 2021
12/10/2020
17.53-0.58-2.08NA
Q1 2021
9/14/2020
13.99-0.61-1.83NA
Q4 2020
7/1/2020
12.12-0.37-1.64NA
Q3 2020
3/10/2020
10.40-0.52-1.76NA
Q2 2020
12/3/2019
15.34-0.33-1.47NA
Q1 2020
9/9/2019
16.60-0.42-1.36NA
Q4 2019
7/15/2019
17.00-0.49-1.41NA
Q3 2019
3/14/2019
31.10-0.23-0.98NA
Q2 2019
12/14/2018
22.68-0.22-1.24NA
Q1 2019
9/14/2018
17.17-0.47-1.52NA
Q4 2018
7/31/2018
9.37-0.06NANA
Q3 2018
3/16/2018
10.07-0.49NANA
Q2 2018
12/14/2017
9.21-0.50NANA
Quotes delayed 20 minutes

Email EnvelopeFree KALV Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
KalVista Pharmaceuticals (KALV) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

KBR PE Ratio History
KDMN PE Ratio History
KDNY PE Ratio History
KEQU PE Ratio History
KIDS PE Ratio History
KIN PE Ratio History
KLDO PE Ratio History
KMPH PE Ratio History
KNTE PE Ratio History
KOD PE Ratio History
How should the KALV historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like KalVista Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this KALV Historical PE Ratio page.

What is the average historical PE for KALV based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The KALV historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for KALV based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The KALV historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the KALV Historical PE Ratio information for KalVista Pharmaceuticals' stock. The average KALV historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average KALV historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this KALV historical PE result, against the recent PE: when this page was posted on 9/9/2022, the most recent closing price for KALV had been 15.87, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on KALV or any other given stock, valuation analysis for KALV can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate KalVista Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for KALV. Thanks for visiting, and the next time you need to research KALV Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Top Ten Hedge Funds Holding TSRE, SRAD shares outstanding history, PJT Average Annual Return.

 

KALV Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.